Patient Perceptions of Integrating Meditation-based Interventions in Office-based Opioid Treatment with Buprenorphine: A Mixed-methods Survey.
Journal of addiction medicine Babak Tofighi, Christina Marini, Joshua D Lee et al. 1 citation
Among 72 patients prescribed buprenorphine for opioid use disorder in office-based opioid treatment, 90.3% reported practicing at least one category of meditation-based intervention (MBI) on at least a daily (39.6%) or weekly (41.7%) basis. The most common type was spiritual meditation (67.7%), followed by nonmantra meditation (61.3%), mindfulness meditation (54.8%), and mantra meditation (29.0%). Interest in MBI was motivated by improving general health and well-being (73.4%), treatment outcomes (60.9%), and relationships (60.9%). Perceived benefits included reduced anxiety or depression (70.3%), pain (62.5%), substance use (60.9%), cravings (57.8%), and withdrawal symptoms (51.6%). The findings suggest high acceptability for adopting MBI in this population.